175 related articles for article (PubMed ID: 34859842)
1. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p.
Su YZ; Cui MF; Du J; Song B
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6827. PubMed ID: 34859842
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis.
Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3397. PubMed ID: 34002806
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647.
Qian C; Liao CH; Tan BF; Chen YF; Dang BW; Chen JL; Liu CB
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8628. PubMed ID: 32964947
[TBL] [Abstract][Full Text] [Related]
4. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p.
Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9240. PubMed ID: 33015761
[TBL] [Abstract][Full Text] [Related]
5. Retraction Note: The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5311. PubMed ID: 35993622
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer.
Wang ZH; Wang JH; Wang KQ; Zhou Y; Wang J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8250. PubMed ID: 32894530
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p.
Zhang C; Wang GX; Fu B; Zhou XC; Li Y; Li YY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7215. PubMed ID: 32706053
[TBL] [Abstract][Full Text] [Related]
8. LncRNA AB073614 promotes tumor migration and invasion by repressing CDKN1A in non-small cell lung cancer.
Zhao WD; Zhang BX; Cui XH; Zhang J; Du N; Zhang YF
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7552. PubMed ID: 32744657
[TBL] [Abstract][Full Text] [Related]
9. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
Li HL; Liang S; Cui JH; Han GY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7574. PubMed ID: 32744679
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer.
Huang K; Fan WS; Fu XY; Li YL; Meng YG
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7211. PubMed ID: 32706049
[TBL] [Abstract][Full Text] [Related]
11. MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9.
Zhen Z; Dong F; Shen H; Wang QG; Yang L; Hu J
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7192. PubMed ID: 34919215
[TBL] [Abstract][Full Text] [Related]
12. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
Pan MZ; Song YL; Gao F
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2156. PubMed ID: 33755945
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells.
Wang H; Xu T; Wu L; Xu HL; Liu RM
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6159. PubMed ID: 34730189
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
Yu X; Wang ZL; Han CL; Wang MW; Jin Y; Jin XB; Xia QH
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7203. PubMed ID: 32706041
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9238. PubMed ID: 33015759
[TBL] [Abstract][Full Text] [Related]
16. Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A.
Bian WG; Zhou XN; Song S; Chen HT; Shen Y; Chen P
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6444. PubMed ID: 34787845
[TBL] [Abstract][Full Text] [Related]
17. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9768. PubMed ID: 33090442
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TTN-AS1 promotes the proliferation and migration of prostate cancer by inhibiting miR-1271 level.
Zhu Y; Yang Z; Luo XH; Xu P
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1165. PubMed ID: 33629283
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer.
Guo JQ; Yang ZJ; Wang S; Wu ZZ; Yin LL; Wang DC
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7218. PubMed ID: 32706056
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of lncRNA SNHG7 inhibits proliferation and invasion of nasopharyngeal carcinoma cells through repressing ROCK1.
Wang L; Xu T; Cui X; Han M; Zhou LH; Wei ZX; Xu ZJ; Jiang Y
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7917. PubMed ID: 32767310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
